Nathan Y. Yu

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

N. Jewel Samadder, Douglas L. Riegert‐Johnson, Deborah J. Rhodes et al. · JAMA Oncology · 2020 · 294 citations · Full text

Life Sciences, Genetics, Oncology +17

Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small‐spot intensity‐modulated proton versus volumetric‐modulated arc therapies

Chenbin Liu, R.S. Bhangoo, Terence T. Sio et al. · Journal of Applied Clinical Medical Physics · 2019 · 56 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors

Nathan Y. Yu, Mauricio E. Gamez, William F. Hartsell et al. · Advances in Radiation Oncology · 2019 · 45 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience

R.S. Bhangoo, T.A. DeWees, Nathan Y. Yu et al. · Advances in Radiation Oncology · 2020 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer

Nathan Y. Yu, T.A. DeWees, Molly M. Voss et al. · Clinical Lung Cancer · 2022 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +12